Residency · Residency · Vascular Surgery
Arterial Wall Structure and Atherosclerosis Pathogenesis
Arterial Wall Anatomy
Three-Layer Structure
The arterial wall is composed of three distinct layers, each with specialized structures and functions. The innermost layer, known as the tunica intima, consists of a single layer of endothelial cells that rest on a basement membrane and subendothelial connective tissue. This layer is bounded externally by the internal elastic lamina (IEL), which provides elasticity and support. Surrounding the intima is the tunica media, which is made up of concentric layers of smooth muscle cells (SMCs) embedded within an extracellular matrix composed of elastin, collagen, and proteoglycans. The media is externally bounded by the external elastic lamina (EEL). The outermost layer, the tunica adventitia, contains fibroblasts, collagen fibers, vasa vasorum (small blood vessels supplying the artery wall), nervi vasorum (nerve fibers), and lymphatic channels. This layer provides structural support and supplies nutrients to the outer parts of the media.
Elastic vs. Muscular Arteries
Arteries can be classified based on the composition of their media. Elastic arteries, such as the aorta, iliac, and carotid arteries, have a media dominated by elastin lamellae. These arteries serve a "Windkessel" function, dampening the pulsatile flow of blood generated by the heart to maintain steady downstream flow. In contrast, muscular arteries, including the superficial femoral artery (SFA), tibial, and renal arteries, have a media dominated by smooth muscle cells. These arteries primarily regulate vascular tone and control regional blood flow. There are transition zones between these types, such as the common femoral artery, which are clinically important because they are often sites where vascular disease preferentially develops.
Endothelial Function
The endothelium plays a critical role in vascular homeostasis. It produces nitric oxide (NO) via endothelial nitric oxide synthase (eNOS), which promotes vasodilation and exerts antiplatelet and anti-inflammatory effects. Additionally, the endothelium synthesizes prostacyclin (PGI2), another vasodilator with antiplatelet properties. In contrast, it also produces endothelin-1, a potent vasoconstrictor, maintaining a balance with NO to regulate vascular tone. The endothelium acts as a selective permeability barrier controlling the passage of molecules and cells. It also expresses anticoagulant surface molecules such as thrombomodulin and heparan sulfate, which prevent thrombosis. Importantly, endothelial dysfunction is the earliest detectable abnormality in the development of atherosclerosis.
Atherosclerosis Pathogenesis
Response-to-Injury Hypothesis (Ross, 1999)
The pathogenesis of atherosclerosis begins with endothelial injury or dysfunction, which is considered the initiating event. Various risk factors—including hypertension, hyperlipidemia, smoking, diabetes, and turbulent blood flow—activate the endothelium. This activation increases endothelial permeability to lipoproteins and promotes leukocyte adhesion, setting the stage for lesion development.
Lipid Infiltration and Oxidation
Low-density lipoprotein (LDL) particles accumulate in the subendothelial space where they become trapped. These retained LDL particles undergo oxidative modification by reactive oxygen species (ROS), producing oxidized LDL (oxLDL). OxLDL acts as a potent pro-inflammatory stimulus, promoting the recruitment of monocytes from the circulation. These monocytes differentiate into macrophages that take up oxLDL through scavenger receptors such as SR-A and CD36. Unlike the normal LDL receptor, these scavenger receptors mediate unregulated uptake, leading to the formation of lipid-laden macrophages known as foam cells.
Inflammatory Cascade
Activated endothelial cells express adhesion molecules including vascular cell adhesion molecule-1 (VCAM-1), intercellular adhesion molecule-1 (ICAM-1), E-selectin, and P-selectin, which facilitate leukocyte adhesion. Monocyte chemoattractant protein-1 (MCP-1) recruits circulating monocytes to the site of injury. These monocytes transmigrate into the intima and differentiate into macrophages under the influence of macrophage colony-stimulating factor (M-CSF). T lymphocytes, predominantly the Th1 subtype, amplify the inflammatory response by secreting interferon-gamma (IFN-γ) and tumor necrosis factor-alpha (TNF-α). Other immune cells such as mast cells, dendritic cells, and B lymphocytes also contribute to the inflammatory milieu.
Plaque Formation and Progression
The earliest visible lesion in atherosclerosis is the fatty streak, which consists of a reversible accumulation of foam cells and is often observed in teenagers. As the disease progresses, smooth muscle cells migrate from the media into the intima, proliferate, and produce extracellular matrix components, forming a fibrous cap over a lipid-rich necrotic core; this lesion is termed a fibroatheroma. Progressive lipid accumulation, cell death through apoptosis and necroptosis, and defective efferocytosis (the clearance of dead cells) enlarge the necrotic core. Calcification occurs as smooth muscle cells undergo osteogenic differentiation. Neovascularization arises from the vasa vasorum within the plaque, increasing the risk of intraplaque hemorrhage.
Plaque Vulnerability and Rupture
Plaques can be classified as stable or vulnerable based on their morphology. Stable plaques have a thick fibrous cap, a small lipid core, and few inflammatory cells. Vulnerable plaques, in contrast, feature a thin fibrous cap less than 65 microns thick, a large lipid core occupying more than 40% of the plaque area, and a dense inflammatory infiltrate with spotty calcification.
| Feature | Stable Plaque | Vulnerable Plaque | |
|---|---|---|---|
| Fibrous cap | Thick | Thin (<65 microns) | |
| Lipid core | Small | Large (>40% plaque area) | |
| Inflammatory cells | Few | Dense infiltrate | |
| Calcification | Diffuse/sheet-like | Spotty | |
| Clinical risk | Low | High (rupture-prone) | Macrophages secrete matrix metalloproteinases (MMP-1, -2, and -9) that degrade collagen in the fibrous cap, weakening it. When the fibrous cap ruptures, the thrombogenic necrotic core is exposed to flowing blood, triggering acute thrombosis. Plaque erosion, characterized by superficial endothelial denudation without rupture, accounts for approximately 30% of acute coronary events and is likely responsible for a significant proportion of peripheral arterial events. |
Sites of Predilection
Atherosclerosis preferentially develops at arterial branch points, bifurcations, and curvatures. These locations experience low and oscillatory wall shear stress (WSS), which promotes endothelial dysfunction. In contrast, straight arterial segments with high WSS are relatively protected from atherosclerosis. This explains the common involvement of sites such as the carotid bifurcation, aortic bifurcation, coronary ostia, and the superficial femoral artery at the adductor hiatus.
Risk Factors
Non-Modifiable
Age is the strongest non-modifiable risk factor for atherosclerosis. Male sex is associated with higher risk, while premenopausal females have some protection due to estrogen. Genetic predisposition also plays a role, with family history and specific gene variants such as those in the LPA gene and the 9p21 locus increasing susceptibility.
Modifiable
Several modifiable risk factors contribute to atherosclerosis. Hyperlipidemia, characterized by elevated LDL cholesterol, low high-density lipoprotein (HDL), and elevated lipoprotein(a), promotes lipid accumulation in the arterial wall. Hypertension causes mechanical injury to the endothelium and increases permeability. Diabetes mellitus leads to the formation of advanced glycation end-products (AGEs), endothelial dysfunction, and a prothrombotic state. Tobacco use exerts direct endothelial toxicity, increases reactive oxygen species, and promotes thrombosis. Chronic kidney disease accelerates calcific atherosclerosis and systemic inflammation. Obesity and metabolic syndrome contribute through insulin resistance and chronic low-grade inflammation.
AHA Classification of Atherosclerotic Lesions
The American Heart Association classifies atherosclerotic lesions into six types based on histological features. Type I lesions are initial lesions characterized by isolated macrophage foam cells. Type II lesions, or fatty streaks, consist of layers of foam cells. Type III lesions are intermediate and contain extracellular lipid pools. Type IV lesions, or atheromas, have a confluent extracellular lipid core. Type V lesions, known as fibroatheromas, feature a lipid core with a fibrous cap (Va), calcification (Vb), or fibrosis without lipid (Vc). Type VI lesions are complicated and include surface defects, hemorrhage, or thrombosis.
| AHA Type | Name | Key Histological Features |
|---|---|---|
| I | Initial lesion | Isolated macrophage foam cells |
| II | Fatty streak | Layers of foam cells |
| III | Intermediate lesion | Extracellular lipid pools |
| IV | Atheroma | Confluent extracellular lipid core |
| Va | Fibroatheroma | Lipid core with fibrous cap |
| Vb | Calcific lesion | Calcification predominant |
| Vc | Fibrotic lesion | Fibrosis without significant lipid |
| VI | Complicated lesion | Surface defect, hemorrhage, or thrombosis |
Systemic Nature of Atherosclerosis
Atherosclerosis is a systemic disease affecting multiple vascular beds. Patients with peripheral artery disease (PAD) have a three- to six-fold increased risk of cardiovascular death compared to age-matched controls. The presence of polyvascular disease, involving multiple arterial territories, is associated with the worst prognosis. Therefore, management of atherosclerosis must be systemic rather than focused solely on local lesions.
<image>Cross-sectional diagram of an artery showing the three layers: tunica intima with endothelial cells and internal elastic lamina, tunica media with smooth muscle cells and elastic fibers, and tunica adventitia with vasa vasorum and collagen fibers. Labels clearly identify each layer and key structures.</image>
<image>Step-by-step illustration of atherosclerotic plaque progression from normal endothelium to fatty streak to fibroatheroma to vulnerable plaque with thin fibrous cap. Show LDL infiltration, monocyte adhesion, foam cell formation, smooth muscle migration, necrotic core development, and fibrous cap thinning with MMP activity. Use a longitudinal cross-section view.</image>
<image>Medical illustration comparing a stable atherosclerotic plaque (thick fibrous cap, small lipid core, few inflammatory cells) versus a vulnerable plaque (thin fibrous cap less than 65 microns, large necrotic core, heavy macrophage infiltration, intraplaque hemorrhage from neovascularization). Include labels for each feature.</image>
<image>Diagram showing arterial bifurcation (such as the carotid bifurcation) with color-coded wall shear stress mapping: high shear stress on the flow divider (atheroprotected) and low/oscillatory shear stress on the outer wall of the bulb (atheroprone). Include flow streamlines showing disturbed flow patterns.</image>
Key Clinical Pearls
Endothelial dysfunction is the earliest detectable abnormality in atherosclerosis and often precedes any visible lesion; importantly, it is potentially reversible with modification of risk factors. Atherosclerosis should be understood fundamentally as an inflammatory disease rather than merely a disorder of lipid storage. The geographic distribution of plaques at arterial bifurcations and bends is explained by low wall shear stress in these regions, which promotes endothelial dysfunction. Vulnerable plaques, characterized by thin fibrous caps and large necrotic cores, are responsible for acute clinical events, making plaque morphology a more critical determinant of risk than the degree of stenosis. All patients with peripheral artery disease require aggressive systemic management of risk factors—including statins, antiplatelet agents, blood pressure and glucose control, and smoking cessation—regardless of whether revascularization is performed. Foam cell formation occurs through unregulated uptake of oxidized LDL by scavenger receptors, bypassing the normal LDL receptor feedback mechanisms.
References
- Ross R. Atherosclerosis -- an inflammatory disease. N Engl J Med. 1999;340:115-126.
- Stary HC et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. Circulation. 1995;92:1355-1374.
- Libby P. Inflammation in atherosclerosis. Nature. 2002;420:868-874.
- Lusis AJ. Atherosclerosis. Nature. 2000;407:233-241.
- Bentzon JF et al. Mechanisms of plaque formation and rupture. Circ Res. 2014;114:1852-1866.
